• By kamiphotos on Adobe Stock
    adobestock_559095551_1
    Erin Brady
    June 13, 2025
    Recent Mayo Clinic research supports the reliability of the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio for diagnosing Alzheimer's, according to a release. The test,...
    ID 196480927 © Iryna Drozd | Dreamstime.com
    dreamstime_xxl_196480927_1
    Image courtesy of LVIS Corporation
    Visual showing NeuroMatch Elite interface by LVIS, featuring a 3D brain model with colored nodes and connecting lines representing brain activity, overlaid on an EEG background. Image courtesy of LVIS Corporation.
    By angellodeco on Adobe Stock
    adobestock_114090939
    ID 80084022 © Per Boge | Dreamstime.com
    dreamstime_xxl_80084022
    ID 159921496 © Oksana Ryzhinskaya | Dreamstime.com
    dreamstime_xxl_159921496
    LABline
    June 6, 2025
    Foresight Diagnostics announced a strategic, worldwide partnership with QIAGEN to develop and commercialize a kit-based version of Foresight’s CLARITY assay, with the goal...
    ID 56463226 © Aviahuismanphotography | Dreamstime.com
    dreamstime_xxl_56463226
    To take the test online go HERE. For more information, visit the Continuing Education tab. LEARNING OBJECTIVES 1. Discuss current statistics of congenital cytomegalovirus (cCMV...
    Courtesy of Randox
    logoheader
    LABline
    June 2, 2025
    Randox Laboratories announced that the U.S. Food and Drug Administration (FDA) has approved the De Novo application for the company’s first Companion Diagnostic (CDx). The...
    ID 181938784 © Douglas Olivares | Dreamstime.com
    dreamstime_xxl_181938784_1
    LABline
    May 28, 2025
    MD Anderson Cancer Center scientists discovered a new biomarker that can predict “survival outcomes for patients with advanced KRAS G12C-mutated non-small cell ...
    ID 342822543 © Rafael Fores | Dreamstime.com
    dreamstime_xxl_342822543_1
    LABline
    May 27, 2025
    Foresight Diagnostics, Inc. announced the presentation of independent validation data demonstrating the prognostic performance of its Foresight CLARITY MRD assay in patients with...
    By LukaszDesign on Adobe Stock
    adobestock_801332965
    LABline
    May 23, 2025
    QIAGEN announced a new commercial partnership and co-marketing agreement with ID Solutions to expand the availability of dPCR assays for oncology research applications.  ...
    ID 355797220 © Dubovdaniilyu | Dreamstime.com
    dreamstime_xxl_355797220
    LABline
    May 22, 2025
    The global C-reactive protein (CRP) testing market, valued at USD 3.3 billion in 2024, is on a path of steady growth, with projections indicating a compound annual growth rate...
    ID 67940812 © Vchalup | Dreamstime.com
    dreamstime_xxl_67940812
    LABline
    May 20, 2025
    Fujirebio announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the first in vitro diagnostic device that tests blood to aid in diagnosing...
    By Keopaserth on Adobe Stock
    adobestock_1168120491
    LABline
    May 19, 2025
    Roche announced that the U.S. Food and Drug Administration (FDA) has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic approved to aid in determining ...
    Courtesy of NIH/NCI
    Slides showing minimal disruption (left) and substantial disruption (right) in breast stromal tissue. Courtesy of NIH/NCI.
    Erin Brady
    May 15, 2025
    National Institutes of Health (NIH) scientists have uncovered a possible breast cancer biomarker that could help distinguish high risk patients and lead to better prevention and...

    Diagnostics

    ID 7990897 © Tomasz Gierygowski | Dreamstime.com
    dreamstime_xxl_7990897
    ID 186155408 © Noipornpan | Dreamstime.com
    dreamstime_xxl_186155408
    ID 56692654 © Sudok1 | Dreamstime.com
    dreamstime_xxl_56692654_1
    ID 215927130 © Hulko Svitlana | Dreamstime.com
    dreamstime_xxl_215927130
    ID 90790974 © Rido | Dreamstime.com
    dreamstime_xxl_90790974
    ID 27116397 © Nyul | Dreamstime.com
    dreamstime_xxl_27116397
    Courtesy of AnalytiChem
    2501ana__redipor_an_analytichem_brand__schematic